Researchers stop the only current HIV vaccine efficacy trial
Gene therapy studies show potential for HIV control without drugs
New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy
Can people with resistant HIV omit NRTIs when switching from a failing regimen?
New pro-drug tenofovir alafenamide appears equally effective but better tolerated
New NNRTI MK-1439 shows promise in early clinical trial
Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect
